Maxi Nicotine
- Product NDC
- 0536-1338
- 11-digit product format
- 005361338
- Labeler code
- 0536
- Product ID
- 0536-1338_21f25fb4-08b3-4f4f-ad3f-3b8e0c6836f2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- nicotine polacrilex
- Dosage form
- LOZENGE
- Route
- ORAL
- Labeler
- Rugby Laboratories, Inc.
- Application
- ANDA209206
- Marketing category
- ANDA
- Marketing start
- 2021-09-17
- Substance
- NICOTINE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209206-001 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | ||
| A209206-002 | NICOTINE POLACRILEX | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209206-001 | NICOTINE POLACRILEX | EQ 2MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209206-002 | NICOTINE POLACRILEX | EQ 4MG BASE | TROCHE/LOZENGE / ORAL | 2018-06-26 | 74a2ff9319b5… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Maxi Nicotine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NICOTINE | 4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6M3C89ZY6R | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 359818 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7c2e0872-75f6-4c4f-afff-3579375708de | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0536-1338-09 | Maxi Nicotine | 3 in 1 BOX | LOZENGE | 3 | 6 | |
| 0536-1338-09 | Maxi Nicotine | 24 in 1 BOTTLE, PLASTIC | LOZENGE | 24 | 6 | |
| 0536-1338-35 | Maxi Nicotine | 24 in 1 BOTTLE, PLASTIC | LOZENGE | 24 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0536-1338-09 | EA - Each | 0536-1338 | 2f593a30-83f0-4a80-b412-4c2c5a8d09aa | 1 | 2021-12-08 |
| 0536-1338-35 | EA - Each | 0536-1338 | 13e0900c-52d2-48de-8ef7-b6aa839d509f | 1 | 2024-12-10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nicotine | NICOTINE POLACRILEX | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | a33b6ed6-2c75-4bab-98e5-a7f8bea21926 | 2026-08-12 | Warnings | 209206 ANDA209206 |
| Nicotine | NICOTINE POLACRILEX | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | 39640129-2d7a-4ec5-81a1-e14b11d3d3ee | 2026-03-12 | Warnings | 209206 ANDA209206 |
| Nicotine | NICOTINE POLACRILEX | Walgreens | 25dc2032-4e6a-440a-8327-7b6c877a2430 | 2026-01-20 | Warnings | 209206 ANDA209206 |
| Nicotine | NICOTINE POLACRILEX | Walgreens | 49a8e4f0-2b4c-4928-98f8-c8f9bb17c0f4 | 2026-01-20 | Warnings | 209206 ANDA209206 |
| Nicotine Sugar Free | NICOTINE POLACRILEX | CVS Pharmacy | a275ff04-4078-4783-932b-dde9aee04682 | 2025-08-26 | Warnings | 209206 ANDA209206 |
| Nicotine Sugar Free | NICOTINE POLACRILEX | CVS Pharmacy | 63fce25d-457f-4048-86a4-1805f603936c | 2025-08-26 | Warnings | 209206 ANDA209206 |
| Maxi Nicotine | NICOTINE POLACRILEX | Rite Aid Corporation | 1472b0a3-5ff1-44e7-8748-a3b1a5e55196 | 2025-08-25 | Warnings | 209206 ANDA209206 |
| Nicotine | NICOTINE POLACRILEX | Rugby Laboratories, Inc. | 150faf42-491f-403b-869b-48edd431d1cc | 2025-07-18 | Warnings | 209206 ANDA209206 |
| Maxi Nicotine | NICOTINE POLACRILEX | Rugby Laboratories, Inc. | 7c2e0872-75f6-4c4f-afff-3579375708de | 2025-07-18 | Warnings | 209206 ANDA209206 0536-1338 |
| Nicotine | NICOTINE POLACRILEX | Cardinal Health (Leader) 70000 | 80195d3b-9341-4354-8a65-b5b080b524d0 | 2025-02-26 | Warnings | 209206 ANDA209206 |
| Maxi Nicotine | NICOTINE POLACRILEX | Cardinal Health (Leader) 70000 | 362b4a04-4a5f-4af6-9cd7-82aa172b7afb | 2025-02-26 | Warnings | 209206 ANDA209206 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 359818 | nicotine 4 MG Oral Lozenge | PSN | 7c2e0872-75f6-4c4f-afff-3579375708de | 6 |
| 359818 | nicotine 4 MG Oral Lozenge | SCD | 7c2e0872-75f6-4c4f-afff-3579375708de | 6 |
| 359818 | nicotine 4 MG (as nicotine polacrilex 22.2 MG) Oral Lozenge | SY | 7c2e0872-75f6-4c4f-afff-3579375708de | 6 |
| 359818 | nicotine 4 MG Troche | SY | 7c2e0872-75f6-4c4f-afff-3579375708de | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0536-1338-09 | 00536133809 | 3 BOTTLE, PLASTIC in 1 BOX (0536-1338-09) / 24 LOZENGE in 1 BOTTLE, PLASTIC | 2021-09-17 | 0000-00-00 | No | No | Current | |
| 0536-1338-35 | 00536133835 | 24 LOZENGE in 1 BOTTLE, PLASTIC (0536-1338-35) | 24 lozenge | 2021-09-17 | No | No | Current |